HCA Healthcare, Inc. $HCA Shares Purchased by Savant Capital LLC

Savant Capital LLC lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 37.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,548 shares of the company’s stock after acquiring an additional 1,246 shares during the period. Savant Capital LLC’s holdings in HCA Healthcare were worth $1,938,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the company. Clearstead Trust LLC lifted its stake in shares of HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after buying an additional 53 shares during the period. Harbor Capital Advisors Inc. boosted its holdings in shares of HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after purchasing an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC acquired a new position in HCA Healthcare in the second quarter valued at $40,000. Compound Global Advisors LLC acquired a new stake in HCA Healthcare in the 3rd quarter worth about $44,000. Finally, True Wealth Design LLC lifted its holdings in shares of HCA Healthcare by 179.5% during the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock worth $47,000 after acquiring an additional 70 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on HCA. UBS Group boosted their target price on shares of HCA Healthcare from $525.00 to $598.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a report on Monday, December 15th. Truist Financial boosted their price target on HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft lifted their price objective on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Finally, TD Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $521.55.

HCA Healthcare Stock Down 2.3%

NYSE HCA opened at $501.89 on Monday. The stock has a market cap of $114.53 billion, a PE ratio of 17.68, a P/E/G ratio of 1.54 and a beta of 1.36. The business has a 50 day moving average price of $479.97 and a two-hundred day moving average price of $443.35. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $527.55.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period in the prior year, the firm earned $6.22 earnings per share. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.78 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.15%.

Insider Activity

In other news, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.